{"id":123250,"name":"DYSTONIA MEDICAL RESEARCH FOUNDATION","slug":"dystonia-medical-research-foundation","state":"TX","country":"United States of America","description":"Promotes Compounding Pharmacy Profession","totalSpending":380000,"filings":38,"yearlySpending":[{"year":2018,"income":40000},{"year":2019,"income":40000},{"year":2020,"income":50000},{"year":2021,"income":40000},{"year":2022,"income":60000},{"year":2023,"income":60000},{"year":2024,"income":50000},{"year":2025,"income":40000}],"issues":[{"code":"BUD","display":"Budget/Appropriations"},{"code":"HCR","display":"Health Issues"}],"firms":["HEALTH AND MEDICINE COUNSEL, LLC"],"lobbyists":["DALE DIRKS","PHILIP GOGLAS","DANE CHRISTIANSEN","KATHERINE CRUZ","JOSHUA FEIN"],"govEntities":["Centers For Disease Control & Prevention (CDC)","HOUSE OF REPRESENTATIVES","Natl Institutes of Health (NIH)","SENATE"],"sampleDescriptions":["FY17 & FY18 L-HHS Appropriations Bill \n\nFY17 & FY18 DoD Appropriations Bill \n\nFY17 & FY18  MilCon-VA \n\nFY18 Approps","NIH RDCRN & other dystonia research \n\nFollow on Biologics \n\nPatients Access to Treatments Act \n\nAccess to Marketplace Insurance Act \n\nFDA, medical device policy\n\nHealthcare Reform, Patient Protections","NIH RDCRN & other dystonia research \n\nFollow on Biologics \n\nPatients Access to Treatments Act \n\nAccess to Marketplace Insurance Act \n\nFDA, medical device policy\n\nHealthcare Reform, Patient Protections","FY17 & FY18 L-HHS Appropriations Bill \n\nFY17 & FY18 DoD Appropriations Bill \n\nFY17 & FY18  MilCon-VA \n\nFY18 Approps","NIH RDCRN & other dystonia research \n\nFollow on Biologics \n\nPatients Access to Treatments Act \n\nAccess to Marketplace Insurance Act \n\nFDA, medical device policy\n\nHealthcare Reform, Patient Protections"]}